Equity · Healthcare
SOLV
Solventum Corporation · NYSE
The line runs $74.43 on 14 May through $81.31 on 17 July, on a scale from $72.5 to $82.5. Days the market did not trade hold the previous close, flat.
The chart above plots the price of SOLV over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 44 sessions over that window: $74.43 on 14 May 2026 through $81.31 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 12, 2026
SOLV insider trades
SOLV has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 13 May 2026.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 63 compensation filings in this window. The figures above count all of them.
SOLV reported financials
SOLV reported revenue of $8.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $1.6B.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
SOLV earnings
Reported figures & scheduled dates · SEC EDGAR filings
SOLV institutional holders
8 of the 45 institutional funds we track reported a SOLV position for the quarter ended 31 Mar 2026 — a combined $675.2M; the latest of those filings landed 15 May 2026.
Source: SEC EDGAR 13F filings
SOLV fails-to-deliver
On 14 Jul 2026, 14 shares of SOLV failed to deliver (about $1K) — the latest of 2 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data
Congressional trades in SOLV
The most recent congressional trade disclosed in SOLV is a sale by J. French Hill (house, AR), dated 31 Dec 2025.
Source: U.S. House of Representatives financial disclosures